Microbiome-based bile acids can potentially cause atherosclerosis and myocardial infarction (MI) through different types of bile acid receptors by reducing bile acid synthesis and increasing plasma LDL cholesterol [104,105]. Here, NR1H4 is linked to atherosclerosis.